HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Sargramostim

HCID 178544287
New reaction
Print

Completing data — refresh the page later to see the latest

Names & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
No structure available

Names & identifiers

Preferred name
Sargramostim
English name
Sargramostim
Molecular weight
0

Names & synonyms

r-HuGM-CSFSargramostimSargramostim USP/EP/BPRecombinant Human Granulocyte Macrophage-Colony Stimulating FactorRecombinant Protein (Human Granulocyte-Macrophage Colony StimulatingFactor)

Database identifiers

CAS
123774-72-1

Properties

Physicochemical properties

NCI Dictionary of Cancer Terms
sargramostim
FDA UNII
5 TAA004E22 · 5TAA004E22
NCI Drug Dictionary
sargramostim
ATC code
3 AA09 · L03AA09
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
315 · H315-H319-H335
Precautionary statements
280 · P280-P261-P271
HS Code
3504009000 · 3504009000

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

hs_code
3504009000
Signal word
Warning
Symbol(GHS)
GHS07
Hazard statements
H315-H319-H335
Precautionary statements
P280-P261-P271

Chemistry & industry

Applications · 3 items

DescriptionSargramostim, a recombinant DNA product, is a granulocyte macrophage colony stimulating factor (GM-CSF) indicated for the treatment of cancer patients after autologous bone marrow transplants. It stimulates immature cells to develop into granulocytes and macrophages and can also switch on mature granulocytes and macrophages.Other indications include improved bone m m w recovery in non-Hodgkins lymphoma and acute lymphoblastic leukemia.

UsesAntineutropenic; hematopoietic stimulant.

General DescriptionSargramostim, rGM-CSF (Leukine), isa glycoprotein commercially produced in genetically engineeredyeast cells. Its polypeptide chain contains 127 aminoacids. It differs from the natural hormone by substitution ofleucine at position 23 and variations in the glycosylation.94Sargramostim is a lineage-nonspecific hematopoietic factor,because it promotes the proliferation and maturation ofgranulocytes (neutrophils and eosinophils) and monocytes(macrophages and megakaryocytes).The primary indication for sargramostim is in myeloidengraftment following autologous bone marrow transplantationand hematopoietic stem cell transplantation. Handling,storage precautions, and adverse effects are similar to thosefor filgrastim.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes